February 13, 2018
291st Edition – February 13, 2018
BioHealth Innovation If you are having trouble viewing this email, please click here February 13,…
February 12, 2018
ABL Europe and SillaJen Expand Strategic Manufacturing Collaboration for Oncolytic Virus Therapies – ABL, Inc.
SillaJen, Inc., (KOSDAQ:215600), a clinical-stage, biotherapeutics company focused on the development of oncolytic immunotherapy products…
February 12, 2018
Researchers Develop Breakthrough Technique to Combat Cancer Drug Resistance – Fischell Department of Bioengineering
The ability for cancer cells to develop resistance to chemotherapy drugs – known as multidrug…
February 12, 2018
11 Startups with JHTV Ties Rank Among Baltimore’s Best – JHTV
In the last six months, Personal Genome Diagnostics (PGDx) raised a $75 million series B,…
February 12, 2018
Denali Therapeutics and Lonza Pharma & Biotech Announce Exclusive Partnership to Develop and Produce Biologic Medicines
Lonza Pharma & Biotech and Denali Therapeutics (NASDAQ: DNLI) announced today an exclusive strategic partnership…
February 12, 2018
The University of Maryland is getting a new $50 million engineering building – The Diamondback
The University System of Maryland Board of Regents voted on Friday to approve the construction…
February 12, 2018
Shepherd Entrepreneurship and Research Corporation achieves nonprofit status | News, Sports, Jobs – Journal News
Shepherd University has created a new nonprofit organization with a mission of helping facilitate research,…
February 12, 2018
New report highlights New York City’s health tech and life science investment landscape – MedCity News
By StartUp Health’s reckoning, New York City was the second most active city for health…
February 12, 2018
Teva Pharmaceuticals chairman, former Medtronic CEO invest in NexImmune – Washington Business Journal
The company overcame early funding challenges with the help of influential backing. (more…)